trending Market Intelligence /marketintelligence/en/news-insights/trending/wyuqxnmvcxrc85izoldpea2 content esgSubNav
In This List

Intra-Cellular Therapies names chief commercial officer

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Intra-Cellular Therapies names chief commercial officer

Intra-Cellular Therapies Inc. appointed Mark Neumann as executive vice president and chief commercial officer.

Neumann most recently was vice president of global marketing at Amgen Inc., prior to which he spent over 25 years with Bristol-Myers Squibb Co. and held commercial roles in neuroscience, cardiovascular and diabetes.

New York-based Intra-Cellular Therapies develops treatments of neuropsychiatric and neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease.